Stable disease and improved health-related quality of life (HRQoL) following fractionated low dose 131I-metaiodobenzyl-guanidine (MIBG) therapy in metastatic paediatric paragan-glioma: observation of false “reverse” discordance during pre-therapy work up and its implication for patient selection for high dose targeted therapy
No Thumbnail Available
Click here to download
Date
2006
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
low dose, 131I-metaiodobenzyl-guanidine, metastatic paediatric paragan-glioma